Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia

about

Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia

Item

http://www.wikidata.org/entity/Q41032396

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Risk assessment of relapse by ...... r acute lymphoblastic leukemia

@en

type

Item

label

Risk assessment of relapse by ...... r acute lymphoblastic leukemia

@en

prefLabel

Risk assessment of relapse by ...... r acute lymphoblastic leukemia

@en

P1476

Risk assessment of relapse by ...... r acute lymphoblastic leukemia

@en

P2093

André Schrauder

http://www.w3.org/2001/XMLSchema#string

Anita Lawitschka

http://www.w3.org/2001/XMLSchema#string

Ansgar Schulz

http://www.w3.org/2001/XMLSchema#string

Bernd Gruhn

http://www.w3.org/2001/XMLSchema#string

Bernhard Kremens

http://www.w3.org/2001/XMLSchema#string

Brigitte Strahm

http://www.w3.org/2001/XMLSchema#string

Christina Peters

http://www.w3.org/2001/XMLSchema#string

Cornelia Eckert

http://www.w3.org/2001/XMLSchema#string

Georg Mann

http://www.w3.org/2001/XMLSchema#string

Gerhard Fritsch

http://www.w3.org/2001/XMLSchema#string

P2860

A revised definition for cure of childhood acute lymphoblastic leukemia.

Interference of dye-associated fluorescence signals with quantitative analysis of chimerism by capillary electrophoresis.

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Vienna experience.

Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.

Outcomes after induction failure in childhood acute lymphoblastic leukemia.

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: a report from the AIEOP registry.

Monitoring of post-transplant remission of childhood malignancies: is there a standard?

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group.

P304

741-746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2015.135137

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Martin Schrappe

Arend von Stackelberg

Renate Panzer-Grümayer

P577

2016-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294108194

http://www.w3.org/2001/XMLSchema#string

P698

26869631

http://www.w3.org/2001/XMLSchema#string

P932

5013947

http://www.w3.org/2001/XMLSchema#string